Tsubota Laboratory Incorporated (TYO:4890)

Tsubota Laboratory Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	710.43	1,357	673	954	640	687
Revenue Growth (YoY)	-44.98%	101.63%	-29.45%	49.06%	-6.84%	55.78%
Cost of Revenue	130.17	180	653	235	84	80
Gross Profit	580.26	1,177	20	719	556	607
Selling, General & Admin	697.37	663	435	394	276	356
Research & Development	254	254	205	126	116	-
Operating Expenses	975.37	941	670	552	420	356
Operating Income	-395.11	236	-650	167	136	251
Interest Expense	-0.69	-1	-1	-	-1	-1
Currency Exchange Gain (Loss)	7.97	38	-	-6	-	-
Other Non Operating Income (Expenses)	25.14	7	14	-17	67	5
EBT Excluding Unusual Items	-361.33	280	-637	144	202	255
Pretax Income	-360.88	280	-637	144	202	255
Income Tax Expense	38.66	75	4	54	49	54
Net Income	-399.54	205	-641	90	153	201
Net Income to Common	-399.54	205	-641	90	153	201
Net Income Growth	-	-	-	-41.18%	-23.88%	6600.00%
Shares Outstanding (Basic)	26	26	25	25	23	22
Shares Outstanding (Diluted)	26	26	25	26	23	22
Shares Change (YoY)	0.85%	1.52%	-0.28%	12.97%	0.70%	0.72%
EPS (Basic)	-15.54	8.01	-25.14	3.66	6.76	8.94
EPS (Diluted)	-15.54	7.92	-25.14	3.52	6.76	8.94
EPS Growth	-	-	-	-47.93%	-24.41%	6552.17%
Free Cash Flow	-	-330	-313	-16	582	-
Free Cash Flow Per Share	-	-12.75	-12.28	-0.63	25.71	-
Gross Margin	-	86.73%	2.97%	75.37%	86.88%	88.35%
Operating Margin	-55.62%	17.39%	-96.58%	17.51%	21.25%	36.54%
Profit Margin	-56.24%	15.11%	-95.25%	9.43%	23.91%	29.26%
Free Cash Flow Margin	-	-24.32%	-46.51%	-1.68%	90.94%	-
EBITDA	-372.36	264	-615	206	173	-
EBITDA Margin	-	19.45%	-91.38%	21.59%	27.03%	-
D&A For EBITDA	22.75	28	35	39	37	-
EBIT	-395.11	236	-650	167	136	251
EBIT Margin	-	17.39%	-96.58%	17.51%	21.25%	36.54%
Effective Tax Rate	-	26.79%	-	37.50%	24.26%	21.18%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.